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It was shown by Collier and Pappenheimer (1) that inhibition, by diphtheria toxin, 
of  amino  acid  incorporation  into  polypeptides  in  cell-free  systems  isolated  from 
mammalian cells requires  the presence of nicotinamide adenine dinucleotide  (NAD) 
as an essential cofaetor. In the absence of NAD, there is no inhibition of amino acid 
incorporation,  even  in  the  presence  of  high  toxin  concentrations.  More  recently, 
Collier  (2) and ourselves (3) have demonstrated that toxin causes inhibition of peptide 
bond formation (in vitro)  by inactivation of a  soluble  enzyme, transferase II. How- 
ever,  the mechanism by which NAD helps to bring about this inactivation has not 
been elucidated. The early studies (1)  had already suggested that the NAD require- 
ment is highly specific  since NAD cannot be  replaced  by nicotinamide adenine  di- 
nucleotide phosphate (NADP). 
In the present paper, we are reporting further experiments on the specificity 
of the NAD requirement for inhibition of amino acid incorporation bydiphtheria 
toxin in cell-free extracts.  A series of NAD analogues have been tested for their 
ability  to replace  NAD  as  a  cofactor for inactivation  of amino  acid transfer 
by the toxin.  The results have been interpreted  as indicating  that interaction 
takes place between toxin and certain of the analogues.  In preliminary experi- 
ments,  such interaction has been demonstrated  directly,  using the method of 
equilibrium dialysis. 
Materials and Methods 
Diphtheria Toxin.--The purified toxin used contained 2.6 #g protein per Lf unit and 60-70 
guinea pig MLD/Lf. The method  of preparation  was similar to that already described (3). 
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Toxin used for equilibrium dialysis contained 11,000  Lf/ml.  Its OD  at  276 m/~ was  26.6. 
Diphtheria Toxoid.--Purified toxoid NZ157P containing 1600 Lf/ml and 1.51 mg N/ml was 
kindly  supplied  by  Mr.  Leo  Levine of  the  Massachusetts Department of Health.  It was 
further fractionated with amnonium sulfate and the fraction precipitating between 0.35 and 
0.6 saturation was collected and dissolved in a  small volume of distilled water. It was then 
filtered through Sephadex GS0. The toxoid used for equilibrium dialysis contained 8500 Lf/ml. 
Its OD at 278 m# was 34.7. 
Cell-Free Extracts.--These were  prepared  from  HeLa  cells and  rabbit reticulocytes.  In- 
corporation of phenylalanine-14C using the synthetic poly U  messenger was followed in the 
cell-free systems as described in detail in the preceding paper (3). 
NAD and Its Analogues.--Nicotlnamide was  purchased from  Nutritional Biochemieals, 
Cleveland, Ohio. Cytochrome c (horse heart, type II), crystalline yeast alcohol dehydrogenase 
(ADH),  reduced  glutathione  (GSH),  NAD,  reduced  nicotinamide  adenine  dinucleotide 
(NADH),  nicotinamide  mononucleotide  (NMN),  deamino-NAD,  thionicotinamide-AD, 
3-acetylpyridine-AD, 3-acetylpyridine-deamino-AD, 3-carbonylpyridine-AD and 3-carbonyl- 
pyridine-deamino-AD were all obtained from Sigma Chemical Co.,  St. Louis, Mo. We are 
indebted to Dr.  Norbert  Swisiocki,  of Brandeis University, who kindly supplied generous 
samples  of  a-NAD,  ethylnicotinate-AD,  3-nicotinylhydroxamic  acid-AD,  4-methylpyri- 
dine-AD,  nicotinamide(1,  2-hydroxyethyl)-AD,  and  4-amino-5-imidazolecarboxamide-AD. 
We also wish to  thank Dr.  A.  W.  Bernheimer, of  New  York  University, who generously 
supplied the NADase used in this work. 
Determination of NAD and NADH.--The method of extraction and assay was similar to 
that described by Glock and McLean (4) except that the cytochrome b6-mediated NADH-cy- 
tochrome c reductase system used was prepared from guinea pig liver microsomes according to 
Chance and Williams (5). NAD was extracted by treating 0.5 ml HeLa extract in 0.1 N HC1 
for 30 see at 100°C followed by homogenizing for 1.4 min in a Potter-Elvejhem type homog- 
enizer. The extract was then quickly chilled and neutralized. NADH was extracted with 0.1 N 
NaOH for 30 see at 100°C,  homogenized, chilled, and neutralized as above. The neutralized 
extracts were centrifuged for 30 min at  20,000 g  and the supemate used immediately for 
assay of NAD or NADH. 
The assay system contained the following components in a total volume of 2.5 mh glycyl- 
glycine buffer, pH 8.7, 0.05 M; ethanol, 0.04 M; antimyein, 1 #g/ml; nicotinamide, 0.03 raM; 
yeast alcohol dehydrogenase, 40 mg/ml; cytochrome c reductase preparation, 0.05 ml; and 
1.5 ml containing the sample to be analyzed. The reaction was initiated by addition of 0.1 ml 
of 1 m~ cytochrome c. Its rate of reduction was measured at 550 m/z and was proportional to 
the NAD or NADH concentration. 
Assay ofNADase Activity.--The  effect of streptococcal NADase on NAD and its analogues 
was examined by the cyanide method of Kapian (6). NAD or one of its analogues was incu- 
bated at 37°C and pH 7.5 with 2100 units NADase for 8 rain in a volume of 0.6 ml. A control 
was incubated in the absence of NADase. 3 ml 1 ~  KCN were then added to stop the reaction, 
and the mixutres were allowed to  stand at  room  temperature for  1 hr before reading  the 
absorbance in the region 325--340 m/z. The exact wavelength used depended on the particular 
NAD analogue. Only those analogues that are capable of being reduced with dithionite form 
cyanide complexes (7). 
Equilibrium Dialysis--Binding  of  NAD  by purified toxin and  toxoid was  measured  by 
equilibrium dialysis using leucite microchambers made by Future Plastics, Inc., Cambridge, 
Mass., according to a  design  suggested  by  Professor H. N. Eisen, Washington University, 
St. Louis, Mo.  Either 60 or 80 #1 purified toxin or toxoid (~3 X  10  --4 M) was placed in one 
chamber, and the same volume of NAD  added  to  the  other  chamber which was  separated 
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tested, ranging from  1.25 X 10  -~ ~ to 2 X 10  -8 it, a control wasrun withbutter (20 mM Tris, 60 
mMKC1, 5mM MgCh.6 H20, pH 7.5) instead of toxin.  After 16-18 hr equilibration, optical 
densities were measured  at 260 m# and 276 m# on samples from each compartment. Calcula- 
tions were made assuming  molar extinctions of 1.6 X  10  ~  for NAD at 260 In# and 6.4  X  105 
for toxin at 276 in#. 
RESULTS 
Failure of NADH  to Replace NAD.--In  the experiment summarized in Table 
I, a  crude extract from HeLa cells was freed from NAD bypassage  through 
Sephadex G25. Then NADH  was added to a  concentration of 0.3 mM and the 
extract was treated for 1 hr at 0°C with 17,000 units of streptococcal NADase. 
The  mixture  was  added  to  the  otherwise  complete  phenylalanine-14C-incor- 
porating system containing 6 #g/ml diphtheria toxin. Table I  shows that phen- 
ylalanine-14C incorporation, in the control that contained 0.03  rnM  NAD  and 
had not been pretreated with NADase, was inhibited 80% by toxin. Within the 
limits of experimental error,  the same  amount  of toxin caused  no  inhibition 
TABLE I 
Failure of NADH to Replace NAD as Cofactor for Toxin Action* 
Additions before pretreatment 
with NADase 
No NADase 
No NADase 
Crude HeLa extract§ 
+  NADH  (3  X  10  -4 it)§ 
Additions after NADase 
Crude HeLa extract~ 
Crude  HeLa  extract  +  toxin 
(6  /~g/ml)  +  NAD  (3  X 
io  -5 ~)~ 
Toxin (6 #g/ml) 
Toxin (6 #g/ml) 
Phenyl- 
afanineJ4C- 
incorporated 
cpm 
3680 
731 
3867 
3409 
Inhibition 
% 
0 
80 
* The incorporating system was the same as described previously (3).  Each tube con- 
rained crude extract from normal HeLa cells, 72 #g poly U and phenylalanineP4C,  2/~c/ml 
(125 #c/gmole) in a final volume of 0.25 ml. After 40 rain at 37°C, the reaction was stopped 
with TCA; the precipitate was collected and assayed in the usual manner. 
$ No NADase added to these tubes. 
§ Pretreated for 1 hr at 0°C with 17,000 units streptococcal NADase before addition of 
toxin and phenylalanine. After 40  rain at 37°C,  NADH concentration  (by analysis) had 
fallen to 5  X  10  ~  it. 
of amino acid uptake in the presence of 10 times as much NADH.  Since strep- 
tococcal NADase does not split NADH  (8), its concentration at the end of the 
experiment could be  determined.  There  was  some disappearance of NADH, 
doubtless because of its oxidation by small mounts  of microsomal cytochrome 
bs that were present in the cell extract. Nevertheless, the final  NADH concen- 
tration was still nearly 0.05 ml~, which is well above the concentration of NAD 
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Analogues of NAD as  Cofactors for Activation  of Diphtheria  Toxin.--The 
analogues that have been tested for their ability to replace NAD in supporting 
the inhibition of protein synthesis by toxin were all compounds that have been 
examined previously for their ability to replace NAD as coenzymes for a variety 
of dehydrogenases (for review,  see reference 9).  They included  analogues of 
the following  types: (a) with substituents  replacing the 3-carboxamide group 
in the pyridine ring;  (b) replacement of the pyridine ring;  (c) alterations in the 
purine ring, and (d) simultaneous alterations in both rings. In order to remove 
traces of NAD that might have remained in  the  HeLa extracts,  even after 
filtration through Sephaxtex G25, and in order to prevent accumulation of any 
TABLE  II 
Inhibition  of Phenylalanine  Incorporation by Diphtheria  Toxin  in the Presence of NAD and 
Rdated Nucleotides* 
Phenyl-  Coenzyme 
Additions to crude HeLa extract  alanine-14C -  Inhibition  activity for 
incorporated  dehydrogenases 
1  2  3  4 
None~ 
Toxin~ 
Toxin +  NAD~ 
Pretreated NADase +  toxin +  NAD 
Nicotinamide 
NMN 
3-Thiocarboxamide pyridine-AD 
3-Acetylpyridine-AD 
Deamino-NAD 
3-Acetylpyridine deamino-AD 
3 -Carbonylpyridine-AD 
3-Carbonylpyridine deamino-AD 
3-Nicotinylhydroxamic acid-AD 
Ethylnicotinate-AD 
a-NAD 
Nicotinamide(1,2-hydroxyethyl)-AD 
4-Amino-5-imidazolecarboxamide-AD 
4-Methylpyridine-AD 
cpm 
4202 
3910 
1175 
4O09 
38O4 
4016 
1099 
2046 
4116 
4028 
3904 
3737 
3986 
3916 
4093 
3998 
3424 
3913 
% 
7 
72 
5 (72)§ 
10 
5 (36) 
74 (70) 
51 (50) 
2 (29) 
5 (6) 
7 (32) 
n  (4) 
5 
7 
2 
5 
19 
7 
Yes 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
* The phenylalanine-t4C incorporating  system  was  as  described  in  Table  I.  All  tubes 
except the control (line 1) contained 3 #g/ml diphtheria toxin. Unless otherwise indicated 
(lines 1-3), each nucleotide was pretreated in the HeLa extract with 1300 units/ml strepto- 
coccal NADase for 1 hr at 0°C before adding toxin and phenylalanine-t4C and bringing to 
37°C. All nucleotides were added so as to give a final concentration of 6 X  10  -~ ~. The final 
concentration of nicotinamide was 8.35  X  10  -3 ~. 
:~ No  pretreatment with NADase. 
§ Numbers in parentheses give per cent inhibition without pretreatment with NADase. RONALD  S. GOOR  AND  A. M. PAPPENIIEIM~R,  JR.  917 
NAD that might have been resynthesized from an analogue due to enzymes 
present  in  the  crude  cell  extracts,  an  excess  of  streptococcal NADase  was 
added to the system before adding toxin and phenylalanine-UC. 
Table II summarizes the ability of a number of compounds related to NAD 
to support inhibition by toxin of phenylalanine incorporation into trichloroacetic 
acid (TCA)-precipitable peptides. Table III summarizes the sensitivity of the 
same  analogues  to  attack by streptococcal NADase.  Column 3  of Table  II 
TABLE III 
Cleavage of Nudeotides  Related to NAD by Streptococcal NADase 
Analogue  Concentration  Abso.rption 
X  10  4  maximum  Cleavage 
NAD 
NMN 
Deamino-NAD 
3-Thiocarboxamide pyridine-AD 
3-Acetylpyridine-AD 
3-Acetylpyridine-AD 
3  -Carbonylpyridine-AD 
3-Carbonylpyridine deamino-AD 
a-NAD 
Nicotinamide  (  1,2-hydroxyethyl)-AD 
Nicotinylhydroxamic  acid-AD 
Ethylnicotinate-AD 
8.34 
4.25 
8.34 
8.34 
8.34 
4.17 
4.17 
4.17 
8.34 
8.34 
8.34 
8.34 
m# 
325 
325 
325 
335 
340 
340 
330 
330 
333 
325 
325 
325 
% 
74.0 
9.5 
68.0 
3.4 
5.8 
2.0 
5.9 
1.0 
0.5 
15.4 
11.4 
0 
Conditions:  Each analogue at the concentration indicated was incubated in the absence 
or presence of 2130 units of streptococcal NADase. Total volume of the incubation mixture 
was 0.6 ml and the pH was 7.5. The reaction was allowed to proceed at 37°C for 8 rain and 
then stopped by adding 3 ml of 1 •  KCN. The mixtures stood at room temperature for 
1 hr before reading the absorbance at the indicated wavelength. 
gives the per cent inhibition for each analogue in extracts that had been pre- 
treated with excess NADase for 1 hr at 0°C before addition of toxin and initia- 
tion of peptide bond formation by adding phenylalanine-14C.  The numbers shown 
in parenthesis give the per cent inhibition observed when the system was not 
pretreated with NADase, although in each case free NAD had been removed 
by gel filtration.  Finally, column 4 indicates whether or not the analogue has 
been found capable of replacing NAD in dehydrogenase reactions at least to 
some  extent.  Many  of  the  analogues  have  been  shown  to  possess  variable 
activity as coenzymes, depending on the particular dehydrogenase system in 
question (Colowick et al., reference 9). 
Inspection of Tables II and III shows that among those NAD analogues 
that  cannot  serve  as  substrates  for  streptococcal  NADase,  only 3-thiocar- 
boxamide pyridine-AD is fully active in replacing NAD as a cofactor for diph- 918  ~ODE  OF  ACTION  OF  DIPHTHERIA  TOXIN.  IV 
theria toxin.  3-acetylpyridine-AD appears to be about 70% as active. Three 
other  nucleotides  related  to NAD  supported  the  toxic inhibition  of phenyl- 
alanine incorporation in the absence of NADase but not in its presence. These 
included  nicotinamide  mononucleotide  (NMN),  3-carbonylpyridine-AD,  and 
deamino-NAD.  Deamino-NAD,  which  appears to be about 40%  as effective 
20 
tO 
o_ 
×  1.0  O 
o 
I 
0.5  1.0 
r 
FIc.  1.  Equilibrium dialysis of diphtheria toxin (3  X  10  -~ ~r)  against increasing concen- 
trations of NAD in 0.02 ~  Tris, pH 7.5, containing 0.06 •  KC1 and 0.005 M MgCh. The equa- 
tion for the straight line is r/c  =  (1  --  r)K  where r  =  bound NAD, c  =  free NAD in moles 
per liter,  and K  =  2.4  X  10  ~ liters/mole. The molecular weight of toxin is taken at 65,000 
(Raynaud et al., reference 11). 
as NAD in the absence of NADase, is shown in Table III to be an excellent 
substrate for the streptococcal enzyme. It would  thus  appear that its failure 
to activate toxin in the presence of NADase was due to its cleavage by this 
enzyme.  On  the other hand,  both NMN  and  3-carbonylpyridine-AD, which 
appeared to activate toxin in the absence of NADase, showed no activity in 
its presence despite the fact that neither analogue can serve as a substrate for 
the enzyme. It seems probable, therefore, that these last two nucleotides were 
converted  to NAD  by  enzymes present  in  the  crude  HeLa extract.  In  the 
presence of NADase,  any resynthesized NAD would, of course, be destroyed 
as fast as it was formed. RONALD S.  GOOR AND A.  M.  PAPPENHEIMER, JR.  919 
Interaction  between Toxin  and  NAD.--The  fact  that  the  only  analogues 
found capable of replacing NAD as cofactors for toxin were nucleotides already 
known to possess coenzyme activity for NAD-linked dehydrogenases suggested 
a possible interaction between toxin and NAD. Preliminary experiments using 
a technic similar to that described by Hummel and Dreyer (10), in which toxin 
was filtered through Sephadex G25 equilibrated with different concentrations 
of NAD, provided direct evidence for such interaction. Reversible binding: of 
1 mole of NAD  per mole of toxin with  an  association constant of  approxi- 
mately 2.4 X  10  a liters/mole, was also demonstrated by equilibrium dialysis. 
In Fig.  1, we have plotted the binding of NAD by 3  X  10  --4 ~  toxin over a 
range of total NAD concentrations varying between 1.25  X  10  -4 M and 2  X 
10  -8 ~. Although the actual K value calculated must still be regarded as tenta- 
tive, since the points show considerable scatter, it is significant that, over the 
same  range  of  NAD  concentrations,  purified  diphtheria  toxoid  showed  no 
detectable binding whatsoever. 
DISCUSSION 
The studies of Collier (2) and of ourselves (3) have shown that diphtheria 
toxin in the presence of NAD inhibits protein synthesis in cell-free extracts 
by  inactivation  of  transferase  II,  one  of  the  soluble  enzymes required  for 
peptide  bond  formation from  aminoacyl-sRNA.  The  experiments  of  Sutter 
and Moldave (12) suggest that this enzyme contains labile --SH groups and 
is  exceedingly sensitive  to  inactivation by oxidation.  The possibilities  that 
first present themselves are,  therefore, (a)  that  toxin may act directly as  a 
NAD-linked dehydrogenase to inactivate transferase II or (b) that toxin may 
activate  a  "latent"  dehydrogenase present  in  inactive form in  cell extracts 
that in turn oxidizes transferase II. The latter possibility seems unlikely be- 
cause  of experiments, reported in  the preceding paper  (3),  in  which  it was 
shown  that,  when extracts from normal and intoxicated cells are mixed to- 
gether, the incorporation is additive. In either case, inactivation of transferase 
II should result in  reduction of NAD  and increased absorption at 340 In#. 
We have been unable to detect any change in absorption resulting from the 
action of toxin, even in cell free systems reconstituted from purified components, 
If NAD is indeed reduced as a  result of toxin inactivation of transferase II, 
then either the yield of NADH is too small to be detected by the means avail- 
able to us, or it is reoxidized as rapidly as it is formed. The latter possibility 
seems  improbable, since the better preparations were free from mitochondria 
and therefore contained little or no cytochrome oxidase. 
The chemical and biological properties of a large series of nucleotides related 
to  NAD  have been  extensively studied  by Kaplan  and  his  coworkers  (7). 
Their work and  that of others on the effectiveness of various analogues,  in- 
cluding all those used in the present study, in replacing NAD  as coenzymes 920  MODE  OF  ACTION  OF  DIPHTHERIA TOXIN.  IV 
for dehydrogenases, has recently been reviewed by Colowick et al.  (9). In no 
case where an analogue had been found to be totally inactive as a  coenzyme 
could it replace NAD as a cofactor for inhibition of protein synthesis by diph- 
theria toxin. On  the other hand,  of those nucleotides found capable of acti- 
vating  various  dehydrogenases  to  a  greater  or  a  lesser  extent,  several  are 
capable  of supporting  inhibition,  by diphtheria  toxin,  of phenylalanine  in- 
corporation into polyphenylalanine. The only analogue  that  we have found 
to be just as effective as NAD, is 3-thiocarboxamide pyridine--AD. However, 
3-acetylpyridine-AD was found to be about  70 %,  and deamino-NAD  about 
40 %, as active as NAD. 
While the results with analogues still do not resolve the question whether or 
not  inhibition  of protein synthesis  in  cell-free extracts  by  toxin  and  NAD 
actually  involves  the  direct  oxidative  inactivation  of  transferase  II,  they 
nevertheless strongly suggest that some sort of interaction between toxin and 
NAD  and  certain  related  nucleotides,  takes  place.  Direct  evidence for  re- 
versible binding of one NAD per molecule of toxin has been demonstrated by 
gel filtration and by equilibrium dialysis.  From the preliminary experiments 
that we have reported, a tentative value of K  =  2.4 X  103 liters per mole has 
been  calculated.  The significance of this  interaction and  its  relation  to  the 
mode of action of diphtheria toxin will be discussed in the paper that follows. 
SUMMARY 
The ability of a number of nucleotides related to NAD to replace NAD as 
cofactors for inhibition  by diphtheria  toxin  of peptide  bond  formation has 
been examined. Neither NADH nor NADP are active. Of some 14 analogues 
closely related structurally  to NAD  that  have been  tested,  only 3-thiocar- 
boxamide pyridine-AD is as active as NAD itself. Replacement of the 3-car- 
boxamide  group  on  the  pyridine  ring  by  an  acetyl group,  or  deamination 
of the purine ring, resulted in derivatives with reduced activity. The results 
were interpreted as suggesting that NAD and certain related nucleotides are 
capable  of specific interaction  with  diphtheria  toxin.  Using  the  method  of 
equilibrium dialysis, reversible binding of 1 mole of NAD per mole of toxin 
has been demonstrated. Toxoid does not interact with NAD. 
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